Navigation Links
Olympus introduces the VisiGlide, a single-use guidewire
Date:10/27/2009

CENTER VALLEY, Pa., October 27, 2009 Olympus, a precision technology leader creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, today announced the availability of VisiGlide1, its new single use guidewire developed with advanced technology from Terumo Corporation2 to facilitate ERCP procedures performed by gastroenterologists. Designed for use in endoscopic treatment of the bile and pancreatic ducts, the new 0.025 inch VisiGlide provides the same level of support and stiffness as a traditional 0.035 inch guidewire. Its enhanced design includes a super-elastic alloy and hydrophilic coatings to facilitate passage through strictures, an abnormal narrowing of a body passage, and makes selective insertion into the bile and pancreatic ducts easier.

By integrating Terumo's advanced materials processing technology with Olympus' endoscope and device combination technology, VisiGlide is expected to provide improved guidewire insertability and maneuverability in the bile and pancreatic ducts sites that are traditionally difficult to reach endoscopically. The core wire of VisiGlide is made of a super-elastic alloy with a thin fluorine coating on its shaft. Its supportive and kink-resistant design combined with its coatings enable the guidewire to pass smoothly through strictures while facilitating the exchange of ERCP devices. These advances in design are expected to make gastrointestinal procedures performed with the ERCP technique faster and easier.

VisiGlide provides visible markings to indicate various distances from the distal end in order to facilitate placement and confirmation of the guidewire's position in the endoscopic field of view during endoscopic treatment and when exchanging devices. This feature is expected to save X-ray radiation time. In addition, two radiopaque markers are incorporated to improve the visibility of the guidewire under fluoroscopy.

Market Introduction Background

In recent years, the occurrence of pancreaticobiliary diseases, such as drainage dysfunction of digestive fluids (bile and pancreatic juice) into the duodenum caused by biliary stricture and papillary stricture due to bile stones and malignant tumors, has been increasing. At the same, therapeutic modalities have been shifting from conventional surgery to endoscopic treatments that are less invasive for patients. The pancreatobiliary ducts are the most difficult site in the gastrointestinal tract to approach endoscopically, resulting in complex and protracted procedures in which multiple devices are variously advanced along a guidewire inserted into the papilla of Vater subsequent to observation of the exterior of the papilla (the opening of the bile and pancreatic ducts) with an endoscope that has been advanced to the duodenum. The VisiGlide is designed to reduce the demands this procedure imposes on doctors and staff and to reduce the time taken to perform it.


'/>"/>

Contact: Megan Longenderfer
Megan.Longenderfer@olympus.com
484-896-5579
GolinHarris International
Source:Eurekalert  

Related biology news :

1. Olympus broadens portfolio with new biliary metallic stent
2. Olympus advances technology for laparo-endoscopic single-site surgery
3. Advanced Analogic Technologies Introduces Lowest-Power Load Switch Available for Biometric Security Devices
4. Motorola Introduces Mobile Biometric Identification for Handheld Computers
5. GN Netcom Introduces Innovative Noise Blackout Technology
6. Silex Introduces SX-SDWAG 802.11a/b/g SDIO Radio Card for OEM Portable Device Applications
7. bioMETRX, Inc. Introduces New Products
8. M2SYS Introduces Revolutionary Biometric Artificial Intelligence Technology to Significantly Reduce Fingerprint Software False Reject Rates
9. ETH Zurich competence center ESC introduces energy strategy
10. Web-Hosted Attendance on Demand(R) Introduces Innovative Web Time Clock
11. Silex Introduces Worlds First Wireless USB Device Server With Streaming Video and Audio Data Transfer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Olympus introduces the VisiGlide, a single-use guidewire
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe ... announced BioLock , an electrocardiogram (ECG) biosensor ... monitoring, a key IoT asset. The smart system ... a vehicle,s steering wheel and mobile devices to ... touch. As vehicle technology advances, so ...
(Date:11/29/2016)... -- Nearly one billion matches per second with DERMALOG,s high-speed ... ... DERMALOG is Germany's largest Multi-Biometric supplier: ... (PRNewsFoto/DERMALOG Identification Systems) ... is Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. ... discovers, develops and plans to commercialize innovative therapeutics ... of common stock were approved for trading on ... trading on the OTCQX, effective today, under the ... the OTCQX market, companies must meet high financial ...
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
(Date:12/7/2016)... McLean, VA (PRWEB) , ... December 07, 2016 ... ... peer-reviewed medical journal has concluded that “in the setting of previously treated, advanced ... Further refinement in defining the optimal patient population and timing of blood sampling ...
Breaking Biology Technology: